Articles

Lilly settles Zyprexa marketing suit for $1.4 billion

Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.

Read More

Q&A

Threats to cut federal Medicare funds that pay for residency training for doctors have eased but not gone away since they were formally proposed by some members of the Congressional super committee last fall. Dr. Peter Nalin, the associate dean of graduate medical education at the Indiana University School of Medicine, said such cuts would be disastrous at a time when patient demands increasingly outstrip the supply of physicians.

Read More

Franciscan to mark Beech Grove closure

Franciscan St. Francis Health announced five years ago that it would consolidate its Beech Grove operations into an expanded hospital seven miles south, near Interstate 65 and Emerson Avenue. The last inpatient department to close at Beech Grove will be its emergency room, on March 16.

Read More

Study: Indy hospitals charge ‘excess’ prices

The Big 3 automakers spent 35 percent more in the Indianapolis area to provide health care for workers and non-elderly retirees than they did in other auto-heavy cities—and two-thirds of that difference can be blamed on “excess prices” by Indianapolis hospitals.

Read More

Lilly plans 200 jobs at new $440M Ireland plant

Eli Lilly and Co. plans to invest about $440 million in a new pharmaceutical plant at an existing company site in County Cork in southern Ireland. The facility in Kinsale will require as many as 200 skilled employees when fully operational.

Read More

SynCare files anticipated bankruptcy

The once fast-growing, Indianapolis-based disease-management company listed in court papers on Tuesday liabilities of nearly $5.7 million and assets of just $125,864.

Read More

Economy could lift drug, device firms

The U.S. economy is showing signs of bouncing back and, if it does, look for drugmakers and medical-device companies to benefit. But if the economy has another summer stall like last year, expect health insurers to benefit.

Read More

Hospitals’ impact less than reported

After years of screaming by employers that spiraling health care spending is crimping their profits and forcing them to hold down wages, the economic impact study released last week by Indiana University Health suggests health care spending is an unmitigated blessing to the Indiana economy.

Read More

Indiana measles outbreak illustrates disease risk

Indiana is battling its second measles outbreak in two years, even though its vaccination rate exceeds the national average. Health officials say the cases, traced to a Super Bowl event, illustrate just how vulnerable the public is to exposure from sources at home and abroad.

Read More

Ex-workers balk at SynCare bankruptcy

Disease management company’s demise in August pushed its CEO Stephanie DeKemper into personal bankruptcy in late December and the company itself will file its own bankruptcy case as early as this week.

Read More

WellPoint fires exec after Medicare woes

WellPoint Inc. finally canned the head of its consumer business after a string of disappointing results, and the move hasn’t further spooked the company’s jittery investors. Although that’s not saying much.

Read More